| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |